These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12769779)

  • 1. The BCL2-family of protein ligands as cancer drugs: the next generation of therapeutics.
    Liu W; Bulgaru A; Haigentz M; Stein CA; Perez-Soler R; Mani S
    Curr Med Chem Anticancer Agents; 2003 May; 3(3):217-23. PubMed ID: 12769779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Progress in small-molecule inhibitors of Bcl-2 family proteins].
    Tang Y; Zhang DY; Wu XM
    Yao Xue Xue Bao; 2008 Jul; 43(7):669-77. PubMed ID: 18819468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells.
    Campàs C; Cosialls AM; Barragán M; Iglesias-Serret D; Santidrián AF; Coll-Mulet L; de Frias M; Domingo A; Pons G; Gil J
    Exp Hematol; 2006 Dec; 34(12):1663-9. PubMed ID: 17157163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of HA14-1 on apoptosis-regulating proteins in HeLa cells.
    Rehman K; Tariq M; Akash MS; Gillani Z; Qazi MH
    Chem Biol Drug Des; 2014 Mar; 83(3):317-23. PubMed ID: 24118733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripheral benzodiazepine receptor ligands induce apoptosis and cell cycle arrest in human hepatocellular carcinoma cells and enhance chemosensitivity to paclitaxel, docetaxel, doxorubicin and the Bcl-2 inhibitor HA14-1.
    Sutter AP; Maaser K; Grabowski P; Bradacs G; Vormbrock K; Höpfner M; Krahn A; Heine B; Stein H; Somasundaram R; Schuppan D; Zeitz M; Scherübl H
    J Hepatol; 2004 Nov; 41(5):799-807. PubMed ID: 15519653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of HA14-1 mediated oxidative stress, toxic response, and autophagy by curcumin to enhance apoptotic activity in human embryonic kidney cells.
    Ranjan K; Sharma A; Surolia A; Pathak C
    Biofactors; 2014; 40(1):157-69. PubMed ID: 23559532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationship studies of ethyl 2-amino-6-bromo-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate (HA 14-1), an antagonist for antiapoptotic Bcl-2 proteins to overcome drug resistance in cancer.
    Doshi JM; Tian D; Xing C
    J Med Chem; 2006 Dec; 49(26):7731-9. PubMed ID: 17181155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
    Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trastuzumab down-regulates Bcl-2 expression and potentiates apoptosis induction by Bcl-2/Bcl-XL bispecific antisense oligonucleotides in HER-2 gene--amplified breast cancer cells.
    Milella M; Trisciuoglio D; Bruno T; Ciuffreda L; Mottolese M; Cianciulli A; Cognetti F; Zangemeister-Wittke U; Del Bufalo D; Zupi G
    Clin Cancer Res; 2004 Nov; 10(22):7747-56. PubMed ID: 15570009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.
    Hata AN; Engelman JA; Faber AC
    Cancer Discov; 2015 May; 5(5):475-87. PubMed ID: 25895919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HA14-1 potentiates apoptosis in B-cell cancer cells sensitive to a peptide disrupting IP 3 receptor / Bcl-2 complexes.
    Akl H; La Rovere RM; Janssens A; Vandenberghe P; Parys JB; Bultynck G
    Int J Dev Biol; 2015; 59(7-9):391-8. PubMed ID: 26260683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel BCL2-specific inhibitor that binds predominantly to the BH1 domain.
    Iyer D; Vartak SV; Mishra A; Goldsmith G; Kumar S; Srivastava M; Hegde M; Gopalakrishnan V; Glenn M; Velusamy M; Choudhary B; Kalakonda N; Karki SS; Surolia A; Raghavan SC
    FEBS J; 2016 Sep; 283(18):3408-37. PubMed ID: 27444341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of myelomonocytic leukemia U937 cells to the induction of apoptosis by the non-peptidic Bcl-2 ligand HA14-1 is cell cycle phase-dependent.
    Reiners JJ; Kessel D
    Cancer Lett; 2005 Apr; 221(2):153-63. PubMed ID: 15808401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3.
    Tzung SP; Kim KM; Basañez G; Giedt CD; Simon J; Zimmerberg J; Zhang KY; Hockenbery DM
    Nat Cell Biol; 2001 Feb; 3(2):183-91. PubMed ID: 11175751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of small-molecule inhibitors of Bcl-2 through structure-based computer screening.
    Enyedy IJ; Ling Y; Nacro K; Tomita Y; Wu X; Cao Y; Guo R; Li B; Zhu X; Huang Y; Long YQ; Roller PP; Yang D; Wang S
    J Med Chem; 2001 Dec; 44(25):4313-24. PubMed ID: 11728179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
    An J; Chervin AS; Nie A; Ducoff HS; Huang Z
    Oncogene; 2007 Feb; 26(5):652-61. PubMed ID: 16909121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mystery of BCL2 family: Bcl-2 proteins and apoptosis: an update.
    Siddiqui WA; Ahad A; Ahsan H
    Arch Toxicol; 2015 Mar; 89(3):289-317. PubMed ID: 25618543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HA14-1, a small molecule Bcl-2 antagonist, induces apoptosis and modulates action of selected anticancer drugs in follicular lymphoma B cells.
    Skommer J; Wlodkowic D; Mättö M; Eray M; Pelkonen J
    Leuk Res; 2006 Mar; 30(3):322-31. PubMed ID: 16213584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes.
    Papadopoulos EI; Yousef GM; Scorilas A
    Biomed Pharmacother; 2015 Mar; 70():33-40. PubMed ID: 25776476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl2 is the guardian of microtubule integrity.
    Haldar S; Basu A; Croce CM
    Cancer Res; 1997 Jan; 57(2):229-33. PubMed ID: 9000560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.